Home
Decheng Capital Global Life Sciences Fund IV reported a 18.3% stake in Aardvark Therapeutics AARD · 3,917,299 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 18.3%
- Last report
- First report
- Shares held
- 3,917,299 sh
- Class
- Common Stock, par value $0.00001 per share
- Event date
- 25/02/14
- Filed
- 25/02/24
First 5%+ report · 18.3% stake
Aardvark Therapeutics trades, last 26 weeks
What else happened in Aardvark Therapeutics around then
Filed or reported within 30 days of the trade day · 25/01/15~25/03/16Decheng Capital Global Life Sciences Fund IV's other 5% stake reports
- Decheng Capital Global Life Sciences Fund IV
5% stakeUpstream Bio
5% stakeUpstream Bio
UPB
5% stake
2,724,868 sh
5% stake
Filed 05/15
- Decheng Capital Global Life Sciences Fund IV
5% stakeUpstream Bio
5% stakeUpstream Bio
UPB
6.1% stake
3,285,293 sh
6.1% stake
Filed 25/02/14
